Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

J&J’s Imaavy secures expanded US approval in rare blood disorder

Aug 25, 2026, 3:38 PM

Read Full Article → J&J’s Imaavy secures expanded US approval in rare blood disorder

J&J’s Imaavy secures expanded US approval in rare blood disorder

Translate article text

Choose a language and wait for the translated text.

The FDA approval marks another successful step in J&J’s aim of achieving $5bn in peak sales for the drug.

J&J’s Imaavy secures expanded US approval in rare blood disorder | PharmaVoice